[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643528":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":29,"responsibleParty":42,"collaborators":11,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":11,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":11,"enrollmentInfo":54,"targetDuration":11,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":11,"overallStatus":32,"whyStopped":11,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Beni-Suef University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"control group","ACTIVE_COMPARATOR",null,[13],"Drug: Standard medical treatment",{"label":15,"type":10,"description":16,"interventionNames":17},"test group","l carnitine",[18,13],"Drug: L Carnitine",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","L Carnitine","L-Carnitine, a natural substance present in the body, is essential for energy metabolism in mammals. l-carnitine presents as a drug.",[15],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"Standard medical treatment","Standard medical treatment for hepatic patient admitted to icu",[9,15],[30],{"facility":31,"status":32,"city":33,"state":11,"zip":11,"country":34,"countryCode":35,"cosmosGeoPoint":11,"geoPoint":11,"contacts":36},"National liver institute","RECRUITING","Menoufia","Egypt","EG",[37],{"name":38,"role":39,"phone":40,"phoneExt":11,"email":41},"Ayten A Abd El-monem","CONTACT","01099850069","aytenamr2023@gmail.com",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Ayten Amr Abd El-monem","Principal Investigator","100643528","phase-4-evaluation-of-the-clinical-impact-of-adjunctive-l-carnitine-therapy-in-critically-ill-hepatic-patients-admitted-to-intensive-care-unit-100643528",false,"NCT07642076","Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit","Inclusion Criteria:\n\n* Age more than 18 years old\n* male or female with confirmed liver disease admitted to intensive care unit, including:\n* Acute-on-chronic liver failure (ACLF)\n* Hepatic encephalopathy\n* spontaneous bacterial peritonitis (SBP)\n* variceal bleeding\n* fulminant hepatitis\n* Hepatorenal syndrome\n* Ascites\n* Etc\n\nExclusion Criteria:\n\n* Age of less than 18 years old\n* Pregnancy or Lactation\n* patients have seizure\n* patient on warfarin","ALL","18 Years",{"count":55,"type":56},58,"ESTIMATED","INTERVENTIONAL",[59],"PHASE4","This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.",[62],"Hepatic","2026-07-18",{"date":65,"type":66},"2026-07-21","ACTUAL",{"date":68,"type":56},"2026-06",{"date":70,"type":56},"2027-03",{"name":5,"class":6},1]